Robert Goodloe
Overview
Explore the profile of Robert Goodloe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
755
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis J, Cui Z, Ghias M, Li X, Goodloe R, Wang C, et al.
J Gastrointest Oncol
. 2022 Jul;
13(3):949-957.
PMID: 35837150
Background: Gastric or gastroesophageal junction (GEJ) adenocarcinoma is the most common form of gastric cancer diagnosed in the United States (US) each year. Diagnosis typically is in later stages of...
2.
Li H, Mawanda F, Mitchell L, Zhang X, Goodloe R, Vincent M, et al.
Pharmaceut Med
. 2022 Jul;
36(4):247-259.
PMID: 35788962
Background: Comparator selection is an important consideration in the design of observational research studies that evaluate potential associations between drug therapies and adverse event risks. It can affect the validity...
3.
Meyers K, Silverberg J, Rueda M, Goodloe R, Pierce E, Deberdt W, et al.
Dermatol Ther (Heidelb)
. 2021 Apr;
11(3):1041-1052.
PMID: 33929715
Introduction: Atopic dermatitis (AD) is associated with risk factors for venous thromboembolism (VTE). However, the risk of VTE among this population is unknown. The aim of this study was to...
4.
Li H, Vincent M, Zhang X, Dennehy E, Goodloe R, Aurora S, et al.
Pain Ther
. 2020 Apr;
9(2):499-509.
PMID: 32328974
Introduction: Migraine is a debilitating neurological disease and one of the most common disorders in the world. Although the triptans, potent 5-HT1B/1D receptor agonists, are an effective and widely used...
5.
Hess L, Cui Z, Mytelka D, Han Y, Goodloe R, Schelman W
Int J Colorectal Dis
. 2019 Jan;
34(4):581-588.
PMID: 30623219
Background: Colorectal cancer is the third most common cause of cancer death in the USA. It is important to identify patients who may experience poor outcomes from available treatments. Methods:...
6.
Cui Z, Hess L, Goodloe R, Faries D
J Comp Eff Res
. 2018 Jun;
7(9):923-934.
PMID: 29925271
Aim: A comparison of conventional pairwise propensity score matching (PSM) and generalized PSM method was applied to the comparative effectiveness of multiple treatment options for lung cancer. Materials & Methods:...
7.
Meyers K, Upadhyaya H, Goodloe R, Kryzhanovskaya L, Liles-Burden M, Kellier-Steele N, et al.
Expert Opin Drug Saf
. 2018 Apr;
17(5):467-473.
PMID: 29625537
Objective: Atomoxetine is a non-stimulant drug indicated for the treatment of attention-deficit/hyperactivity disorder in children aged ≥6 years, adolescents, and adults. In this retrospective cohort study, the incidence and risk...
8.
Goodloe R, Farber-Eger E, Boston J, Crawford D, Bush W
AMIA Jt Summits Transl Sci Proc
. 2017 Aug;
2017:102-111.
PMID: 28815116
Body mass index (BMI) is an important outcome and covariate adjustment for many clinical association studies. Accurate assessment of BMI, therefore, is a critical part of many study designs. Electronic...
9.
Farber-Eger E, Goodloe R, Boston J, Bush W, Crawford D
AMIA Jt Summits Transl Sci Proc
. 2017 Aug;
2017:50-57.
PMID: 28815105
We describe here the extraction of country-of-origin, an acculturation variable relevant for gene-environment studies, in a biorepository linked to de-identified electronic health records (EHRs) assessed by the Epidemiologic Architecture for...
10.
Fernandez-Rhodes L, Gong J, Haessler J, Franceschini N, Graff M, Nishimura K, et al.
Hum Genet
. 2017 Apr;
136(6):771-800.
PMID: 28391526
Most body mass index (BMI) genetic loci have been identified in studies of primarily European ancestries. The effect of these loci in other racial/ethnic groups is less clear. Thus, we...